Thomson Reuters Co. (TSE:TRI – Get Free Report) (NYSE:TRI) Director Michael Goddard sold 133 shares of Thomson Reuters stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of C$131.86, for a total transaction of C$17,537.38. Following the transaction, the director directly owned -2 shares of the company’s stock, valued at approximately C($263.72). This represents a 101.53% decrease in their ownership of the stock.
Thomson Reuters Stock Performance
Thomson Reuters stock opened at C$108.61 on Friday. The company has a debt-to-equity ratio of 20.72, a current ratio of 0.60 and a quick ratio of 0.52. The firm has a market capitalization of C$47.41 billion, a P/E ratio of 31.45, a price-to-earnings-growth ratio of 3.64 and a beta of 0.11. Thomson Reuters Co. has a 1-year low of C$107.91 and a 1-year high of C$299.24. The company’s 50-day moving average is C$127.36 and its 200 day moving average is C$155.22.
Thomson Reuters (TSE:TRI – Get Free Report) (NYSE:TRI) last released its earnings results on Tuesday, May 5th. The company reported C$1.71 EPS for the quarter. Thomson Reuters had a return on equity of 12.64% and a net margin of 19.92%.The firm had revenue of C$2.90 billion for the quarter. Research analysts forecast that Thomson Reuters Co. will post 5.6395803 EPS for the current year.
Analyst Upgrades and Downgrades
About Thomson Reuters
Thomson Reuters is the result of the $17.6 billion megamerger of Canada’s Thomson and the United Kingdom’s Reuters Group in 2008 and the 2018 carve-out of its finance and risk business, Refinitiv, in which it holds a 45% stake. In 2019, the company agreed to exchange its 45% stake in Refinitiv for a 15% stake in LSE. Since the divestiture, the company is more concentrated on selling its flagship legal data and software, WestLaw, and its tax accounting software, OneSource. In addition, the company does hold a significant investment in the publicly traded Tradeweb, which operates a fixed income exchange.
Featured Stories
- Five stocks we like better than Thomson Reuters
- 2 Ways to Play the Big Pharma Patent Cliff
- YETI Rallies After Earnings Beat and Raised Outlook
- How the 3 Leading Quantum Firms Stack Up After Q1 Earnings
- Cisco’s Vertical Rally May Still Be in the Early Innings
Receive News & Ratings for Thomson Reuters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thomson Reuters and related companies with MarketBeat.com's FREE daily email newsletter.
